Down syndrome: why it occurs and what is important to know

Down syndrome is a genetic condition in which a person has an extra, full or partial, copy of chromosome 21. Most commonly, it is called complete trisomy 21, where all cells contain three copies of chromosome 21 instead of two. The extra genetic material alters brain and body development, so the spectrum of symptoms includes distinctive physical features, variable intellectual and speech difficulties, and an increased incidence of a number of congenital and acquired diseases. [1]

This condition is not an infection, is not associated with "abnormal behavior" during pregnancy, and in most cases is not inherited in a typical familial pattern. In the vast majority of families, Down syndrome occurs as a random event during germ cell division or in the early stages of embryonic development. Therefore, the conversation about Down syndrome should not be conducted within a framework of blame, but rather within a framework of accurate diagnosis, respectful counseling, and lifelong medical support. [2]

It's also important to understand that Down syndrome is not a "one-size-fits-all" diagnosis. The clinical picture is highly variable. Some children experience predominantly cardiac and feeding difficulties in infancy, while others experience hearing, vision, thyroid function, or sleep problems. Still others experience a relatively mild course with good adaptation. A modern approach is based on an individualized monitoring plan, not on standardized concepts. [3]

Epidemiology and codes

Down syndrome remains the most common chromosomal condition diagnosed in newborns. According to MedlinePlus, it occurs in approximately 1 in 700 newborns, and the CDC reports that approximately 5,775 babies are born with the condition in the United States each year. These estimates vary slightly by source and country, but the overall picture is consistent: it is one of the most important conditions in clinical genetics and perinatal medicine. [4]

Clinical documentation uses International Classification of Diseases codes. For practical purposes, it is important to specify not only the familiar ICD-10 code but also the ICD-11 equivalent, as many systems are gradually transitioning to the new classification. [5]

Table 1. Codes and main forms

Position	Code
ICD-10, trisomy 21, meiotic nondisjunction	Q90.0
ICD-10, mosaic trisomy 21	Q90.1
ICD-10, translocation trisomy 21	Q90.2
ICD-10, Down syndrome, unspecified	Q90.9
ICD-11, complete trisomy 21	LD40.0

Table basis: WHO ICD-10 classification and reference materials for ICD-11. [6]

Causes and genetic mechanisms

The most common mechanism is meiotic nondisjunction, which is an error in chromosome distribution during the formation of an egg or, less commonly, sperm. As a result, the embryo receives an extra copy of chromosome 21, and this copy is then present in all cells of the body. According to a clinical report from the American Academy of Pediatrics, this form accounts for approximately 96% of cases, with approximately 95% of such episodes occurring in the egg. [7]

The translocation form is much less common, occurring in approximately 3%-4% of cases. In this situation, extra material from chromosome 21 is attached to another chromosome. Clinical manifestations may resemble complete trisomy 21, but genetic counseling is especially important here, as some of these cases are associated with carriage of a balanced translocation in one of the parents. [8]

The mosaic form accounts for approximately 1%-2% of cases according to the AAP and less than 5% according to the NICHD, reflecting differences in classification approaches and detection methods. In mosaicism, some cells have a normal set of chromosomes, while others have an extra chromosome 21. This is why the severity of the phenotype can vary greatly: some people have milder manifestations, although predicting the percentage of mosaicism from a single blood test is not always possible. [9]

Table 2. Genetic forms of Down syndrome

Form	Estimated frequency	The essence of the mechanism	Hereditary component
Complete trisomy 21	95%-96%	An extra 21st chromosome in all cells	Usually no
Translocation form	3%-4%	Extra material from chromosome 21 is attached to another chromosome	Sometimes yes
Mosaic form	1%-2%, sometimes described as less than 5%	The extra 21st chromosome is present only in some cells	Usually no

Table based on: AAP, MedlinePlus, NICHD. [10]

Risk factors, inheritance and recurrence risk

The most well-known risk factor is maternal age. The likelihood of chromosomal nondisjunction increases with age, so age-related risk does indeed increase. However, it's clinically important not to oversimplify: Down syndrome can occur in pregnancy in women of any age, and a significant proportion of children with this condition are born to women under 35 simply because there are more births in this age group overall. [11]

Most cases are not inherited. MedlinePlus emphasizes that in both the common and mosaic forms of trisomy 21, the chromosomal error most often occurs as a random event. Inheritance is of practical importance primarily in the translocation form, when one parent may be a carrier of a balanced translocation without any clinical manifestations of their own. [12]

If a child is diagnosed with a translocation, karyotyping is recommended for both parents. The AAP states that for the 14;21 translocation, the mother is the carrier in approximately 90% of cases, and the risk of recurrence for a carrier mother is estimated at 10%-15%, while for a carrier father it is 2%-5%. For the 21;21 translocation, the risk of recurrence can reach 100%, so proper genetic counseling is essential. [13]

After one previous pregnancy with trisomy 21, the risk of recurrence is generally considered low, but not zero. NHS Genomics Education emphasizes that germline mosaicism should be considered in rare cases, especially if there have been two or more affected pregnancies. This is another reason why families should receive personalized counseling based on the results of a specific karyotype rather than general advice from the internet. [14]

Table 3. How to interpret family risk

Situation	What does this mean in practice?
Complete trisomy 21 without familial translocation	Usually a random event, recurrence risk is low
Mosaic form	Usually a random event, recurrence risk is usually low
Translocation form in a child	Karyotyping of both parents is required.
Mother is a carrier of the balanced translocation 14;21	The risk of recurrence is higher, approximately 10%-15%.
Father is a carrier of the balanced translocation 14;21	The risk of recurrence is higher, approximately 2%-5%
Balanced translocation 21:21 in parent	Very high risk of recurrence

Table based on: AAP, MedlinePlus, NHS Genomics Education. [15]

Clinical features and associated conditions

The Down syndrome phenotype consists not only of characteristic external features but also of a set of medical risks that must be actively monitored. The CDC and AAP list the most common problems as congenital heart defects, hearing impairment, ophthalmologic abnormalities, obstructive sleep apnea, thyroid disease, feeding difficulties, certain gastrointestinal abnormalities, and an increased risk of certain hematological complications. [16]

Cardiology is especially important in the neonatal period. According to the CDC, 50%-65% of infants with Down syndrome are born with a congenital heart defect, and the AAP recommends echocardiography for all newborns with this diagnosis, regardless of prenatal echocardiography results. AV canal defects, septal defects, and other congenital defects can determine the severity of the condition already in the first weeks of life. [17]

Problems with breathing, sleep, hearing, and feeding are equally significant. The AAP cites high rates of hearing loss, ear infections, eye problems, feeding difficulties, and sleep apnea; however, up to 90% of children with aspiration may not cough or have overt symptoms. This means that a child's "calm" appearance does not rule out severe dysphagia, occult aspiration, or sleep-disordered gas exchange. [18]

Endocrine and hematological risks also should not be underestimated. Some children are diagnosed with congenital or acquired hypothyroidism, subclinical changes in thyroid function, autoimmune thyroiditis, celiac disease, transient anomalous myelopoiesis, and an increased risk of leukemia. Most of these conditions are amenable to monitoring and treatment, but only if examinations are performed according to a plan rather than "on a whim." [19]

Table 4. Common comorbidities

State	Estimated frequency
Congenital heart defects	40%-65%
Hearing loss	up to 75%
Obstructive sleep apnea	50%-79%
Otitis with effusion	50%-70%
Vision problems	60%-80%
Feeding difficulties	31%-80%
Thyroid diseases	24%-50%
Celiac disease	1%-5%
Transient anomalous myelopoiesis	about 9%-10%
Leukemia in childhood	about 1%

Table based on CDC and AAP. Ranges vary by age and study design.[20]

Diagnosis during pregnancy

A modern prenatal approach begins with screening rather than immediate invasive testing. The NHS emphasizes that Down syndrome screening is offered to all pregnant women, and the decision to undergo it remains the woman's choice. The purpose of screening is to assess probability, not to make a definitive diagnosis. [21]

In the first trimester, the primary screening option remains a combination screening, which includes a blood test and ultrasound evaluation, including a nuchal translucency test. For those seeking screening later, a second-trimester quad test is available. Following a "high probability" result, a more accurate cell-free fetal DNA screening test and diagnostic procedures may be offered. [22]

The Society for Maternal-Fetal Medicine reports that cfDNA screening is one of the most accurate screening methods for conditions like Down syndrome. However, even this test remains a screening test. If a family requires a definitive answer, the diagnosis is confirmed by chorionic villus sampling or amniocentesis with chromosome analysis. The distinction between "highly accurate screening" and "confirmed diagnosis" should be clearly explained during the consultation. [23]

If a fetal congenital heart defect is suspected, fetal echocardiography is also important. The CDC advises that if an atrioventricular septal defect is suspected, a routine ultrasound can be supplemented with fetal echocardiography, which better depicts the heart's structure and function. For pregnancies with confirmed trisomy 21, this helps plan the birthing location and neonatal care in advance. [24]

Table 5. Screening and confirmation of diagnosis during pregnancy

Method	What does it give?	Status
Combined screening of the first trimester	Probability assessment	Screening
Second trimester quad test	Probability assessment	Screening
cfDNA, a non-invasive prenatal test	A more accurate probability estimate	Screening
Chorionic villus sampling	Chromosomal confirmation	Diagnostics
Amniocentesis	Chromosomal confirmation	Diagnostics
Fetal echocardiography	Assessment of the structure and function of the fetal heart	Additional targeted examination

Table based on: NHS, SMFM, CDC. [25]

Diagnosis after birth

If the diagnosis was made prenatally, a formal review of the chromosomal findings and their inclusion in the child's medical records is still required after birth. If only cfDNA screening was performed during pregnancy or prenatal records are unavailable, the AAP recommends taking blood from the newborn for karyotyping to confirm the diagnosis and rule out translocation. [26]

A physical examination in the first hours and days of life often suggests Down syndrome, but clinical findings are not a substitute for laboratory confirmation. The AAP recommends that if Down syndrome is suspected, blood should be sent for karyotyping, and if necessary, FISH can be used to provide a rapid preliminary answer within 24-48 hours. However, a positive FISH is not a substitute for a complete karyotype because it does not identify the translocation. [27]

Chromosomal microarray analysis is not considered the optimal method for this specific task, as it does not reliably distinguish classic trisomy 21 from unbalanced translocations. Therefore, in clinical practice, karyotype remains the key test for postnatal confirmation of Down syndrome. This is especially important for subsequent familial risk calculation. [28]

Observation of the child after confirmation of the diagnosis

Once the diagnosis is confirmed, a child should not be left under general observation "as complaints arise." A proactive start-up plan is needed for a newborn. The AAP recommends that all infants with Down syndrome undergo echocardiography, evaluate feeding, thyroid function, and the risk of hematologic complications, and, if necessary, promptly involve a cardiologist, hematologist, lactation specialist, and other specialized physicians. [29]

Screening for hearing, vision, and sleep is not an afterthought; it is the foundation of long-term prognosis. Hearing impairment, ear infections, refractive errors, and sleep apnea are extremely common in children with Down syndrome. The AAP recommends repeated audiological screenings, regular ophthalmological evaluations, and polysomnography for all children with Down syndrome at 3-4 years of age, even if parents do not notice significant nocturnal symptoms. [30]

The thyroid gland requires special attention. The AAP recommends monitoring thyroid-stimulating hormone levels at 6 and 12 months, and then annually thereafter, as the risk of acquired thyroid disease increases with age. This approach prevents a situation in which a child's lethargy, speech delay, or weight gain are attributed to "Down syndrome itself," when in fact, some of the problems are related to hypothyroidism and require treatment. [31]

Early intervention should begin as early as possible. The CDC defines early intervention as a system of services and supports for children with developmental delays and their families and indicates that it may include speech, physical, and other therapies that can significantly impact skill acquisition and success in school and daily life. The AAP specifically recommends initiating referrals for speech, fine motor, and gross motor interventions as early as the first month of life, unless medically contraindicated. [32]

Table 6. Basic plan for child observation

Stage	What is important to do
Newborn period	Karyotype, echocardiography, feeding assessment, thyroid examination, complete blood count as indicated
The first year of life	Hearing, vision, growth and feeding monitoring, early intervention
6 and 12 months	Thyroid stimulating hormone control
Preschool age	Repeated audiological and ophthalmological examinations
3-4 years	Polysomnography to rule out sleep apnea
Then annually	Thyroid, developmental, hearing, vision, nutritional and associated conditions assessment

Table basis: AAP, CDC. [33]

Treatment and assistance

There is currently no specific treatment that "removes" the extra genetic material. Therefore, treatment for Down syndrome is not a single procedure or drug, but a multi-level care model: cardiology for congenital heart defects, audiology and otolaryngology for hearing impairments, ophthalmology, endocrinology, gastroenterology, neurology, hematology, speech therapy and physical rehabilitation, and psychological and pedagogical support. [34]

Some children require surgical treatment for congenital heart defects or gastrointestinal anomalies, while others require hearing correction, glasses, hypothyroidism treatment, sleep apnea therapy, celiac disease, or hematological complications. Early and targeted correction of associated conditions often has a greater impact on quality of life than the presence of trisomy 21 itself. This is why modern guidelines emphasize active problem identification and correction rather than passive observation. [35]

Family support is especially important. The AAP recommends discussing the child's strengths, offering support resources, informing about support groups, and involving the family in choosing treatments. This approach reduces anxiety, helps the family move more quickly from the shock of the diagnosis to a practical action plan, and improves adherence to care. [36]

Table 7. Main areas of assistance

Direction	What is it for?
Cardiology	Detection and treatment of congenital heart defects
Audiology and ENT	Early detection of hearing loss and ear infections
Ophthalmology	Correction of visual impairments and prevention of vision loss
Endocrinology	Control of hypothyroidism and other endocrine disorders
Feeding and dysphagia specialists	Correction of aspiration, slow feeding and poor weight gain
Speech therapy	Development of communication and speech understanding
Physical and occupational therapy	Development of motor skills, self-care skills and participation in everyday life
Psychologist and teaching team	Support for behavior, learning, and social adaptation

Table basis: AAP, CDC. [37]

Adult management and aging

Thanks to improved medical care, people with Down syndrome are increasingly living into adulthood and old age. The JAMA guidelines for adults note that average life expectancy has increased significantly, reaching approximately 60 years by 2020. This changes the very logic of observation: an adult patient with Down syndrome needs not only social support but also comprehensive primary care for adults. [38]

One of the key differences in adulthood is the high risk of Alzheimer's disease and Alzheimer's-type dementia. The JAMA guidelines made a single strong recommendation: begin dementia screening at age 40. The US National Institute on Aging reports that by age 40, most people with Down syndrome already have amyloid plaques in their brains, and 50% or more of adults eventually develop Alzheimer's-type dementia. [39]

In addition to cognitive aging, adults should be systematically monitored for obesity, diabetes, thyroid disease, celiac disease, cardiovascular risk factors, and mental health. The guidelines for adults emphasize that regular, rather than occasional, contact with primary care allows for early detection of abnormalities and the avoidance of late complications. [40]

Forecast

The prognosis for Down syndrome today is determined not by a single number or a single "average" scenario, but by the quality of long-term care. Most children with this condition can grow, learn, develop speech, motor, and social skills, and live active lives as adults, provided cardiac, endocrine, hearing, vision, respiratory, and other problems are addressed promptly. The CDC emphasizes that proper medical care helps people with Down syndrome live as long and healthy a life as possible. [41]

The most common reasons for an unfavorable course are not related to the syndrome's name itself, but to missed complications: late-diagnosed heart defects, unrecognized aspiration, severe sleep apnea, hypothyroidism, hematological problems, or late diagnosis of dementia in adults. Therefore, it is more accurate to talk not about "what is the prognosis for Down syndrome in general," but rather about "how early are associated conditions identified and treated in a particular person." [42]

When to see a doctor urgently

In newborns and infants, cyanosis, signs of cardiac or respiratory distress, severe feeding difficulties, choking, episodes of desaturation, lethargy, poor weight gain, and any signs of a lower respiratory infection require immediate evaluation. The AAP emphasizes that in Down syndrome, breathing and feeding problems may be more serious than they appear.[43]

Bleeding, petechiae, recurrent fevers, bone pain, marked lethargy, and changes in appetite in a child with or without transient anomalous myelopoiesis are particularly concerning, as these signs may require urgent exclusion of hematological pathology. In adults, noticeable decline in memory and skills, new behavioral changes, sleep disturbances, episodes of apnea, unexplained weight loss, and signs of decompensation of chronic diseases are reasons for a rapid assessment. [44]

FAQ

Can Down syndrome occur in parents without a family history?

Yes. Most cases are not inherited and arise as a random chromosomal error during the formation of germ cells or in the early stages of embryonic development. The familial mechanism is especially important for some translocation forms. [45]

Is it true that a non-invasive prenatal test already makes a diagnosis?

No. cfDNA is a very accurate screening method, but it is not a confirmatory diagnostic test. A definitive prenatal diagnosis is made by an invasive test, such as chorionic villus sampling or amniocentesis, with chromosomal analysis. [46]

Should all newborns with Down syndrome have an echocardiogram?

Yes. The American Academy of Pediatrics and the CDC recommend echocardiography for all infants with Down syndrome because congenital heart defects are common and not always immediately obvious clinically.[47]

Should I look for sleep apnea if my child doesn't snore?

Yes. Sleep apnea is common in children with Down syndrome, and parental reports do not always reliably reflect the severity of the disorder. Therefore, the AAP recommends polysomnography for all children aged 3–4 years. [48]

Can a child with Down syndrome develop well?

Yes. The rate of development is usually different from the typical, but early intervention, correction of hearing, vision, sleep, nutrition, thyroid function and other associated problems significantly improve the functional outcome. [49]

Why do adults with Down syndrome need a separate care plan?

Because metabolic, endocrine, psychiatric, and cognitive risks, including Alzheimer's-related dementia, increase in importance in adulthood, adult monitoring should be as systematic as that of children. [50]

Key points from experts

Marilyn J. Bull, MD, FAAP, co-author of the American Academy of Pediatrics' clinical report on the management of children and adolescents with Down syndrome, effectively articulates a key pediatric principle: once the diagnosis is confirmed, an age-specific, pre-defined monitoring plan is needed, not just a response to existing complaints. This approach requires echocardiography, monitoring of hearing, vision, thyroid function, sleep, and development. [51]

Amy Y. Tsou, MD, first author of the JAMA guideline for the management of adults with Down syndrome, and the task force behind that document shifted the focus of adult care from "general observation" to evidence-based screening for key risks. The guideline's strongest recommendation is to begin screening for Alzheimer's-type dementia at age 40, reflecting the real clinical significance of cognitive aging in Down syndrome. [52]

Brian Chicoine, MD, medical director of the Adult Down Syndrome Center and co-author of the adult guideline, presents a practical primary care perspective: adults with Down syndrome require comprehensive family and internal medicine, not just disability-specific care. This means regular assessment of weight, metabolism, endocrine disorders, celiac disease, mental health, and cognitive changes. [53]

George Capone, MD, director of the Down Syndrome Clinic and Research Center at the Kennedy Krieger Institute and co-author of the adult guidelines, emphasizes the multidisciplinary nature of care: in Down syndrome, physical health cannot be separated from neurobehavioral and mental health aspects. In practice, this means that sleep, behavioral, adaptation, and cognitive impairments should be included in routine clinical assessment rather than considered an afterthought. [54]